These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3570698)

  • 1. Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol.
    Southren AL; l'Hommedieu D; Gordon GG; Weinstein BI
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):901-3. PubMed ID: 3570698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5 beta-Dihydrocortisol: possible mediator of the ocular hypertension in glaucoma.
    Southren AL; Gordon GG; l'Hommedieu D; Ravikumar S; Dunn MW; Weinstein BI
    Invest Ophthalmol Vis Sci; 1985 Mar; 26(3):393-5. PubMed ID: 3972522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of glaucoma with 3 alpha, 5 beta-tetrahydrocortisol: a new therapeutic modality.
    Southren AL; Wandel T; Gordon GG; Weinstein BI
    J Ocul Pharmacol; 1994; 10(1):385-91. PubMed ID: 8207341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dexamethasone-induced cytoskeletal changes in cultured human trabecular meshwork cells by tetrahydrocortisol.
    Clark AF; Lane D; Wilson K; Miggans ST; McCartney MD
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):805-13. PubMed ID: 8603865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits.
    Melena J; Santafé J; Segarra J
    J Pharmacol Exp Ther; 1998 Jan; 284(1):278-82. PubMed ID: 9435188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
    Chiselită D;
    Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma.
    Hotehama Y; Mishima HK; Kitazawa Y; Masuda K
    Jpn J Ophthalmol; 1993; 37(3):270-4. PubMed ID: 8295364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroid induced ocular hypertension and glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):15-33. PubMed ID: 19899544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased intraocular pressure in mice treated with dexamethasone.
    Whitlock NA; McKnight B; Corcoran KN; Rodriguez LA; Rice DS
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6496-503. PubMed ID: 20671272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
    Pang IH; Moll H; McLaughlin MA; Knepper PA; De Santis L; Epstein DL; Clark AF
    Exp Eye Res; 2001 Dec; 73(6):815-25. PubMed ID: 11846512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Shimmyo M
    Am J Ophthalmol; 2005 Jun; 139(6):1148; author reply 1148-9. PubMed ID: 15953471
    [No Abstract]   [Full Text] [Related]  

  • 13. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Brandt JD; Beiser JA; Gordon MO; Kass MA;
    Am J Ophthalmol; 2004 Nov; 138(5):717-22. PubMed ID: 15531304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
    J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma--a pilot study. Punctal Plugs in Glaucoma Study Group.
    Bartlett JD; Boan K; Corliss D; Gaddie IB
    J Am Optom Assoc; 1996 Nov; 67(11):664-8. PubMed ID: 8979659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular hypotensive activity of pirbuterol eye drops in rabbits.
    Bonomi L; Perfetti S; Bellucci R; De Franco I
    J Ocul Pharmacol; 1991; 7(3):191-4. PubMed ID: 1686050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5 alpha-dihydrocortisol in human aqueous humor and metabolism of cortisol by human lenses in vitro.
    Weinstein BI; Kandalaft N; Ritch R; Camras CB; Morris DJ; Latif SA; Vecsei P; Vittek J; Gordon GG; Southren AL
    Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):2130-5. PubMed ID: 2055703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
    McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
    J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.